Trade Bristol Myers ^BMY

Collegium Pharmaceutical (COLL) Q4 Earnings: What To Expect

How Investors May Respond To Bristol Myers Squibb (BMY) Iberdomide Priority Review And Reblozyl Trial Progress

Assessing Bristol Myers Squibb (BMY) Valuation After Key Multiple Myeloma And Alpha Thalassemia Updates

FDA Review Of Iberdomide Puts Fresh Focus On Bristol Myers Valuation

Barclays Initiates Bristol Myers (BMY) with Overweight Rating on Pipeline Potential

FDA Iberdomide Review Puts Focus On Bristol-Myers Squibb Valuation Gap

AMG National Trust Bank Reduces Position in Bristol Myers Squibb Company $BMY

Supernus Pharmaceuticals (SUPN) To Report Earnings Tomorrow: Here Is What To Expect

Innovative approaches for lung cancer screening and interception

Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer

Michels Family Financial LLC Buys Shares of 11,058 Bristol Myers Squibb Company $BMY - Markets Daily

Citigroup Inc. Lowers Stock Position in Bristol Myers Squibb Company $BMY

Inspire Trust Co. N.A. Acquires 10,000 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Lansforsakringar Fondforvaltning AB publ Raises Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Upgraded to "Strong-Buy" at Barclays

Bristol Myers Squibb Company $BMY Position Trimmed by Jupiter Asset Management Ltd.

King Luther Capital Management Corp Sells 18,602 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Prothena Corp PLC (PRTA) Q4 2025 Earnings Call Highlights: Strategic Advancements and Financial ...

Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profiling

Pfizer Oncology And Rare Disease Milestones Shape Long Term Growth Prospects

Where is Janux Therapeutics (JANX) Headed According to Analysts?

What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)?

Iberdomide Review And AI Alliance Add New Angles To BMY Outlook

Pzena Investment Management LLC Acquires 58,129 Shares of Bristol Myers Squibb Company $BMY

Pzena Investment Management LLC Raises Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Axxcess Wealth Management LLC Has $3.49 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Maridea Wealth Management LLC Raises Stock Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases

Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development | Morningstar

Bristol Myers Squibb Company $BMY Shares Purchased by Advisors Capital Management LLC

We Like Bristol-Myers Squibb's (NYSE:BMY) Earnings For More Than Just Statutory Profit - Simply Wall St News

NEOS Investment Management LLC Acquires 35,641 Shares of Bristol Myers Squibb Company $BMY

Public Sector Pension Investment Board Trims Stock Position in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by Public Sector Pension Investment Board - Stock Observer

U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs

Vanguard Group Inc. Has $8.84 Billion Stock Holdings in Bristol Myers Squibb Company $BMY

GSA Capital Partners LLP Purchases 14,260 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Skandinaviska Enskilda Banken AB publ Has $167.77 Million Position in Bristol Myers Squibb Company $BMY

As Tech Struggles, US Dividend Stocks Step Back Into the Limelight | Morningstar UK

What Bristol-Myers Squibb (BMY)'s Earnings Rebound and Completed Buybacks Mean For Shareholders - Simply Wall St News

The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D

Bristol Myers Squibb Company $BMY Stock Position Lifted by M&G PLC - Zolmax

Bristol Myers Squibb Company $BMY Shares Acquired by M&G PLC

Bristol Myers Squibb Company $BMY Shares Purchased by State of New Jersey Common Pension Fund D

Shell Asset Management Co. Has $1.52 Million Stake in Bristol Myers Squibb Company $BMY

Assetmark Inc. Buys 34,057 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Holdings Raised by State of New Jersey Common Pension Fund D - Stock Observer

PNC Financial Services Group Inc. Sells 480,848 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Position Increased by denkapparat Operations GmbH - Daily Political

Clinical progress of engineered cellular immunotherapies for autoimmunity

Assessing Bristol-Myers Squibb (BMY) Valuation After Earnings Beat And Newer Drug Growth

Bristol Myers Squibb Company $BMY Stock Holdings Decreased by TCTC Holdings LLC - Markets Daily

Berkshire Asset Management LLC PA Trims Stock Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Aberdeen Group plc

Bristol-Myers Squibb Earnings Strength And Pipeline Shape Future Valuation

Here's What Analysts Are Saying About Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus

Bristol Myers Squibb Company $BMY Stock Holdings Lessened by Cibc World Market Inc.

Bristol Myers Squibb Company $BMY Shares Sold by Rhumbline Advisers

Krilogy Financial LLC Grows Position in Bristol Myers Squibb Company $BMY

As Tech Struggles, Dividend Stocks Step Back Into the Limelight | Morningstar

Caisse Des Depots ET Consignations Sells 21,113 Shares of Bristol Myers Squibb Company $BMY

LSV Asset Management Purchases 138,119 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company (NYSE:BMY) Given Average Rating of "Hold" by Analysts - Stock Observer

SC Refuses to Bar Zydus from Selling Biosimilar of BMS' Cancer Drug - The Economic Times

SC refuses stay on Zydus cancer drug launch, tells BMS to seek relief in HC | Health News - Business Standard

Wealthfront Advisers LLC Has $15.04 Million Stake in Bristol Myers Squibb Company $BMY - Daily Political

Is Bristol Myers Squibb (BMY) Pricing Reflecting Its Recent Share Price Rebound?

Bristol-Myers Squibb (BMY) Is Up 8.7% After Profit Rebound And Pipeline Outlook - Has The Bull Case Changed?

New York Life Investment Management LLC Lowers Stock Position in Bristol Myers Squibb Company $BMY

Bristol-Myers Squibb (BMY) Is Up 8.7% After Swing To Profit And AI-Focused R&D Push - Simply Wall St News

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T cells in lymph nodes

Assessing Bristol Myers Squibb (BMY) Valuation After Earnings Beat And Pipeline Optimism

Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight

Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating

Oppenheimer Asset Management Inc. Purchases 32,005 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Envestnet Asset Management Inc.

Candriam S.C.A. Cuts Stake in Bristol Myers Squibb Company $BMY

Prognostic impact of myelodysplasia-related gene mutations in FLT3 -ITD-mutated acute myeloid leukemia

Bristol Myers Squibb Company $BMY Shares Acquired by Plato Investment Management Ltd - Markets Daily

Kinsale Capital Group Inc. Has $7.61 Million Stock Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Alps Advisors Inc.

Birmingham Capital Management Co. Inc. AL Reduces Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Twin Capital Management Inc.

Bristol Myers Squibb (BMY) Returns To US$7.1b Trailing Profit Challenging Bearish Narratives

What Catalysts Are Rewriting The Story For Bristol Myers Squibb (BMY)?

Bristol Myers Squibb Company $BMY Shares Sold by Wells Trecaso Financial Group LLC

Bristol Myers Squibb (NYSE:BMY) Given New $64.00 Price Target at Citigroup - Daily Political

HORAN Wealth LLC Makes New $454,000 Investment in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Q4 Earnings Call Highlights

Bristol Myers Squibb (NYSE:BMY) Releases Quarterly Earnings Results, Misses Expectations By $0.39 EPS - Markets Daily

Bristol Myers Squibb (NYSE:BMY) Announces Quarterly Earnings Results, Misses Estimates By $0.39 EPS

Bristol Myers Squibb CEO: Richest product pipeline we've had in the last decade

Bristol's Portfolio of Newer Therapies and Strong Late-Stage Pipeline Support a Wide Moat | Morningstar